Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of GBP 124.20 million. The enterprise value is 8.53 million.

Market Cap	124.20M
Enterprise Value	8.53M

Important Dates

The last earnings date was Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.38%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.51M

Valuation Ratios

The trailing PE ratio is 74.36.

PE Ratio	74.36
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 0.45, with an EV/FCF ratio of 0.63.

EV / Earnings	5.11
EV / Sales	0.02
EV / EBITDA	0.45
EV / EBIT	0.70
EV / FCF	0.63

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.

Current Ratio	3.34
Quick Ratio	2.53
Debt / Equity	0.08
Debt / EBITDA	0.68
Debt / FCF	0.95
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 1.02% and return on invested capital (ROIC) is 4.27%.

Return on Equity (ROE)	1.02%
Return on Assets (ROA)	3.24%
Return on Invested Capital (ROIC)	4.27%
Return on Capital Employed (ROCE)	6.99%
Revenue Per Employee	954,820
Profits Per Employee	3,314
Employee Count	634
Asset Turnover	2.03
Inventory Turnover	3.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.47% in the last 52 weeks. The beta is 1.17, so Medifast's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	-69.47%
50-Day Moving Average	16.57
200-Day Moving Average	19.13
Relative Strength Index (RSI)	41.20
Average Volume (20 Days)	308

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.76

Income Statement

In the last 12 months, Medifast had revenue of GBP 481.23 million and earned 1.67 million in profits. Earnings per share was 0.15.

Revenue	481.23M
Gross Profit	355.15M
Operating Income	12.29M
Pretax Income	3.02M
Net Income	1.67M
EBITDA	15.09M
EBIT	12.29M
Earnings Per Share (EPS)	0.15

Full Income Statement

Balance Sheet

The company has 129.68 million in cash and 12.88 million in debt, giving a net cash position of 116.80 million.

Cash & Cash Equivalents	129.68M
Total Debt	12.88M
Net Cash	116.80M
Net Cash Per Share	n/a
Equity (Book Value)	167.83M
Book Value Per Share	15.75
Working Capital	120.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.55 million and capital expenditures -5.95 million, giving a free cash flow of 13.60 million.

Operating Cash Flow	19.55M
Capital Expenditures	-5.95M
Free Cash Flow	13.60M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.80%, with operating and profit margins of 2.55% and 0.35%.

Gross Margin	73.80%
Operating Margin	2.55%
Pretax Margin	0.63%
Profit Margin	0.35%
EBITDA Margin	3.14%
EBIT Margin	2.55%
FCF Margin	2.83%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	34.19%
Buyback Yield	-0.38%
Shareholder Yield	-0.38%
Earnings Yield	1.34%
FCF Yield	10.95%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 6.23.

Altman Z-Score	6.23
Piotroski F-Score	n/a